Skip to main content

Table 6 Success rate, 3 and 6 months following thoracoscopic talc pleurodesis.

From: Early and late morbidity and mortality and life expectancy following thoracoscopic talc insufflation for control of malignant pleural effusions: a review of 400 cases

PATIENTS
MALIGNANCY Success Rate after 3 months (340/400) [85%] Success Rate after 6 months (328/400) [82%]
Non small cell lung cancer 136/166 [81.9] 130/166 [78.3]
Breast cancer 94/97 [96.9] 91/97 [93.8]
Ovarian cancer 22/24 [91.6] 22/24 [91.6]
Uterine cancer 13/16 [81.2] 12/16 [75.0]
Colon cancer 13/16 [81.2] 12/16 [75.0]
Sarcoma 11/14 [78.5] 10/14 [71.4]
Gastric cancer 10/13 [76.9] 10/13 [76.9]
Lymphoma 11/13 [84.6] 11/13 [84.6]
Small cell lung cancer 8/10 [80.0] 8/10 [80.0]
Pleural mesothelioma 8/10 [80.0] 8/10 [80.0]
Melanoma 5/7 [71.4] 5/7 [71.4]
Oesophageal cancer 2/4 [50.0] 2/4 [50.0]
Testicular cancer 3/4 [75.0] 3/4 [75.0]
Hepatocellular cancer 2/3 [66.6] 2/3 [66.6]
Parotid gland cancer 1/2 [50.0] 1/2 [50.0]
Gallbladder cancer 1/1 [100.0] Death with no recurrence